Investigational Drug Information for Tecarfarin
✉ Email this page to a colleague
What is the drug development status for Tecarfarin?
Tecarfarin is an investigational drug.
There have been 3 clinical trials for Tecarfarin.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2018.
The most common disease conditions in clinical trials are Thrombosis, Thromboembolism, and [disabled in preview]. The leading clinical trial sponsors are Lee's Pharmaceutical Limited, Armetheon Inc, and Espero Biopharma.
Summary for Tecarfarin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2018-06-01) |
| Vendors | 0 |
Recent Clinical Trials for Tecarfarin
| Title | Sponsor | Phase |
|---|---|---|
| An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers | Lee's Pharmaceutical Limited | Phase 1 |
| A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers | Lee's Pharmaceutical Limited | Phase 1 |
| Tecarfarin Anti-Coagulation Trial (TACT) | Armetheon Inc | Phase 3 |
Clinical Trial Summary for Tecarfarin
Top disease conditions for Tecarfarin
Top clinical trial sponsors for Tecarfarin
US Patents for Tecarfarin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
